Research programme: hepatocyte growth factor-related proteins - Dompe

Drug Profile

Research programme: hepatocyte growth factor-related proteins - Dompe

Alternative Names: Metron F1

Latest Information Update: 01 Sep 2010

Price : $50

At a glance

  • Originator Dompe Farmaceutici
  • Class Recombinant proteins
  • Mechanism of Action Hepatocyte growth factor stimulants; Macrophage colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • No development reported Alopecia; Stomatitis

Most Recent Events

  • 05 Mar 2007 Preclinical development is ongoing
  • 15 Dec 2004 This compound is still in active development
  • 09 Sep 1997 Preclinical development for Haematological disorders in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top